These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8107656)

  • 1. B19 parvovirus infection in children with malignant solid tumors receiving chemotherapy.
    Rao SP; Miller ST; Cohen BJ
    Med Pediatr Oncol; 1994; 22(4):255-7. PubMed ID: 8107656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parvovirus B19 as a cause of chronic anemia in rhabdomyosarcoma.
    Shaw PJ; Eden T; Cohen BJ
    Cancer; 1993 Aug; 72(3):945-9. PubMed ID: 8334647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progressive bicytopenia due to persistent parvovirus B19 infection after immunochemotherapy with fludarabine/cyclophosphamide and rituximab for relapsed B cell lymphoma.
    Hartmann JT; Meisinger I; Kröber SM; Weisel K; Klingel K; Kanz L
    Haematologica; 2006 Dec; 91(12 Suppl):ECR49. PubMed ID: 17194655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of chemotherapy-induced toxicities in younger children and adolescents with rhabdomyosarcoma: a report from the Children's Oncology Group Soft Tissue Sarcoma Committee.
    Gupta AA; Anderson JR; Pappo AS; Spunt SL; Dasgupta R; Indelicato DJ; Hawkins DS
    Cancer; 2012 Feb; 118(4):1130-7. PubMed ID: 21761400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parvovirus B19-induced persistent pure red cell aplasia in a child with T-cell immunodeficiency.
    Tavil B; Sanal O; Turul T; Yel L; Gurgey A; Gumruk F
    Pediatr Hematol Oncol; 2009 Mar; 26(2):63-8. PubMed ID: 19322736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An unresolved issue in rhabdomyosarcoma treatment: The duration of chemotherapy.
    Bisogno G; Hawkins DS
    Pediatr Blood Cancer; 2020 May; 67(5):e28174. PubMed ID: 31994316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistent human parvovirus B19 infection in children under maintenance chemotherapy for acute lymphocytic leukemia.
    Fattet S; Cassinotti P; Popovic MB
    J Pediatr Hematol Oncol; 2004 Aug; 26(8):497-503. PubMed ID: 15284587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Veno-occlusive disease in a child with rhabdomyosarcoma after conventional chemotherapy: report of a case and review of the literature.
    Cecen E; Uysal KM; Ozguven A; Gunes D; Irken G; Olgun N
    Pediatr Hematol Oncol; 2007 Dec; 24(8):615-21. PubMed ID: 18092252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parvovirus B19 infection associated with encephalitis in a patient suffering from malignant lymphoma.
    Heegaard ED; Peterslund NA; Hornsleth A
    Scand J Infect Dis; 1995; 27(6):631-3. PubMed ID: 8685646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the rates of response to ifosfamide and cyclophosphamide in primary unresectable rhabdomyosarcomas.
    Treuner J; Koscielniak E; Keim M
    Cancer Chemother Pharmacol; 1989; 24 Suppl 1():S48-50. PubMed ID: 2667790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ifosfamide-induced renal tubular defect.
    Torres Valdivieso MJ; López Pérez J; Melero C; Vivanco JL; Muley R; Vara J
    Med Pediatr Oncol; 1994; 22(2):144-6. PubMed ID: 7505048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parvovirus B19 infection in a child with acute lymphoblastic leukemia during induction therapy.
    McNall RY; Head DR; Pui CH; Razzouk BI
    J Pediatr Hematol Oncol; 2001; 23(5):309-11. PubMed ID: 11464989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fifty years of rhabdomyosarcoma studies on both sides of the pond and lessons learned.
    Arndt CAS; Bisogno G; Koscielniak E
    Cancer Treat Rev; 2018 Jul; 68():94-101. PubMed ID: 29940525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Irreversible encephalopathy with ifosfamide/mesna.
    Salloum E; Flamant F; Ghosn M; Taleb N; Akatchereian C
    J Clin Oncol; 1987 Aug; 5(8):1303-4. PubMed ID: 3114437
    [No Abstract]   [Full Text] [Related]  

  • 15. Anhydramnios and cessation of fetal growth in a pregnant mother with polychemotherapy during the second trimester.
    Fernandez H; Diallo A; Baume D; Papiernik E
    Prenat Diagn; 1989 Sep; 9(9):681-2. PubMed ID: 2798354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful high-titer immunoglobulin therapy for persistent parvovirus B19 infection in a lymphoma patient treated with rituximab-combined chemotherapy.
    Isobe Y; Sugimoto K; Shiraki Y; Nishitani M; Koike K; Oshimi K
    Am J Hematol; 2004 Dec; 77(4):370-3. PubMed ID: 15558805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Venoocclusive disease of the liver after chemotherapy with vincristine, actinomycin D, and cyclophosphamide for the treatment of rhabdomyosarcoma. A report of the Intergroup Rhabdomyosarcoma Study Group. Childrens Cancer Group, the Pediatric Oncology Group, and the Pediatric Intergroup Statistical Center.
    Ortega JA; Donaldson SS; Ivy SP; Pappo A; Maurer HM
    Cancer; 1997 Jun; 79(12):2435-9. PubMed ID: 9191535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone marrow necrosis and human parvovirus associated infection preceding an Ph1+ acute lymphoblastic leukemia.
    Petrella T; Bailly F; Mugneret F; Caillot D; Chavanet P; Guy H; Solary E; Waldner A; Devilliers E; Carli PM
    Leuk Lymphoma; 1992 Nov; 8(4-5):415-9. PubMed ID: 1290967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transient acquired myelodysplasia associated with parvovirus B19 infection in a patient with congenital spherocytosis.
    Rinn R; Chow WS; Pinkerton PH
    Am J Hematol; 1995 Sep; 50(1):71-2. PubMed ID: 7668238
    [No Abstract]   [Full Text] [Related]  

  • 20. Secondary leukemia in a child conceived using in vitro fertilization.
    Kim YD; Kim KJ; Lee YH
    Pediatr Int; 2008 Dec; 50(6):831-2. PubMed ID: 19067904
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.